BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26376962)

  • 1. Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.
    Sandulache VC; Chen Y; Skinner HD; Lu T; Feng L; Court LE; Myers JN; Meyn RE; Fuller CD; Bankson JA; Lai SY
    Mol Cancer Ther; 2015 Dec; 14(12):2901-8. PubMed ID: 26376962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic interrogation as a tool to optimize chemotherapeutic regimens.
    Sandulache VC; Chen Y; Feng L; William WN; Skinner HD; Myers JN; Meyn RE; Li J; Mijiti A; Bankson JA; Fuller CD; Konopleva MY; Lai SY
    Oncotarget; 2017 Mar; 8(11):18154-18165. PubMed ID: 28184025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.
    Blatt S; Voelxen N; Sagheb K; Pabst AM; Walenta S; Schroeder T; Mueller-Klieser W; Ziebart T
    Clin Oral Investig; 2016 Nov; 20(8):2097-2104. PubMed ID: 26728026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
    Skinner HD; Sandulache VC; Ow TJ; Meyn RE; Yordy JS; Beadle BM; Fitzgerald AL; Giri U; Ang KK; Myers JN
    Clin Cancer Res; 2012 Jan; 18(1):290-300. PubMed ID: 22090360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profile of biomarkers altered in papillary and anaplastic thyroid carcinoma: Contribution of Tunisian patients.
    Fourati A; El Amine O; Ben Ayoub W; Cherni I; Goucha A; El May MV; Gamoudi A; El May A
    Bull Cancer; 2017 May; 104(5):433-441. PubMed ID: 28185633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas.
    Burrows N; Williams J; Telfer BA; Resch J; Valentine HR; Fitzmaurice RJ; Eustace A; Irlam J; Rowling EJ; Hoang-Vu C; West CM; Brabant G; Williams KJ
    Oncotarget; 2016 Sep; 7(39):63106-63123. PubMed ID: 27527858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets.
    Skvortsov S; Jimenez CR; Knol JC; Eichberger P; Schiestl B; Debbage P; Skvortsova I; Lukas P
    Radiother Oncol; 2011 Oct; 101(1):177-82. PubMed ID: 21700351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status.
    Sandulache VC; Skinner HD; Ow TJ; Zhang A; Xia X; Luchak JM; Wong LJ; Pickering CR; Zhou G; Myers JN
    Cancer; 2012 Feb; 118(3):711-21. PubMed ID: 21720999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice.
    Quennet V; Yaromina A; Zips D; Rosner A; Walenta S; Baumann M; Mueller-Klieser W
    Radiother Oncol; 2006 Nov; 81(2):130-5. PubMed ID: 16973228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
    Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
    J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation.
    Guihard S; Ramolu L; Macabre C; Wasylyk B; Noël G; Abecassis J; Jung AC
    Int J Oncol; 2012 Oct; 41(4):1531-40. PubMed ID: 22895816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of cell cycle mediator protein expression patterns in anaplastic and papillary thyroid carcinoma.
    Evans JJ; Crist HS; Durvesh S; Bruggeman RD; Goldenberg D
    Cancer Biol Ther; 2012 Jul; 13(9):776-81. PubMed ID: 22688732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.
    Maniakas A; Henderson YC; Hei H; Peng S; Chen Y; Jiang Y; Ji S; Cardenas M; Chiu Y; Bell D; Williams MD; Hofmann MC; Scherer SE; Wheeler DA; Busaidy NL; Dadu R; Wang JR; Cabanillas ME; Zafereo M; Johnson FM; Lai SY
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4652-e4665. PubMed ID: 34147031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin/BIRC5 as a novel molecular effector at the crossroads of glucose metabolism and radioresistance in head and neck squamous cell carcinoma.
    Benaiges E; Ceperuelo-Mallafré V; Guaita S; Maymó-Masip E; Madeira A; Gómez D; Hernández V; Vilaseca I; Merma C; León X; Terra X; Vendrell J; Avilés-Jurado FX; Fernández-Veledo S
    Head Neck; 2024 Jul; 46(7):1752-1765. PubMed ID: 38305029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a rational strategy for integration of lactate dehydrogenase A suppression into therapeutic algorithms for head and neck cancer.
    Chen Y; Maniakas A; Tan L; Cui M; Le X; Niedzielski JS; Michel KA; Harlan CJ; Lu W; Henderson YC; Mohamed ASR; Lorenzi PL; Putluri N; Bankson JA; Sandulache VC; Lai SY
    Br J Cancer; 2021 May; 124(10):1670-1679. PubMed ID: 33742144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.
    Oweida A; Phan A; Vancourt B; Robin T; Hararah MK; Bhatia S; Milner D; Lennon S; Pike L; Raben D; Haugen B; Pozdeyev N; Schweppe R; Karam SD
    Thyroid; 2018 Jun; 28(6):739-747. PubMed ID: 29774792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolysis-related gene induction and ATP reduction during fractionated irradiation. Markers for radiation responsiveness of human tumor xenografts.
    Goetze K; Meyer SS; Yaromina A; Zips D; Baumann M; Mueller-Klieser W
    Strahlenther Onkol; 2013 Sep; 189(9):782-8. PubMed ID: 23828461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
    Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
    Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.